The Early Effects of Esketamine on the Tumor Metastatic Microenvironment in Postoperative Lung Cancer Patients
The Clinical Respiratory Journal · 2025-08 · 19 (8)
DOI: 10.1111/crj.70108 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 13.08.2025. Verfasst von Yong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Forth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Ketamine, Tumor Microenvironment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
To investigate the early effect of esketamine on the tumor metastatic microenvironment in patients with lung cancer.
Methods
Sixteen adults aged 45–80 years with the American Society of Anesthesiologists (ASA) 1 to 3 were randomly divided into the experimental group (group E) and the control group (group C). Group E received esketamine at 1 mg/kg during anesthesia induction and a continuous infusion of 0.5 mg/kg/h during the surgery. Group C was given the same amount of normal saline infusion. Patient‐controlled intravenous analgesia (PCIA) in group E was administered using dexmedetomidine (0.5 mg/kg) + esketamine (50 mg) + dexamethasone (5 mg). PCIA in group C was the same dose of dexmedetomidine and dexamethasone. Data were recorded at 14 points from admission to the third day after surgery (T 0–14 ). Parameters recorded included hemodynamics, wake time, remifentanil dosage, and so on. At T 0 , T 10 , T 13 , and T 14 , TNF‐α, IL‐2, IL‐10, MMP‐9, and VEGF‐C were measured.
Results
Compared with T 0 , the differences of tumor necrosis factor‐α (TNF‐α), interleukin‐2 (IL‐2), matrix metallopeptidase 9 (MMP‐9), and vascular endothelial growth factor‐C (VEGF‐C) in the two groups were statistically significant ( p < 0.05). When compared to group C, VEGF‐C in group E was reduced at T 10 and T 13 ( p < 0.05). For both groups, there were intragroup differences in the changes of MMP‐9 and VEGF‐C levels ( p < 0.05). Compared to group C, on the postoperative, group E exhibited a lower change rate of TNF‐α and VEGF‐C ( p < 0.05).
Conclusion
Perioperative application of esketamine in patients with lung cancer provided significant sedative and analgesic effects and affected cytokines in the tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Forth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.
ORCID-Profile: Huiqun Jia
Zitieren
APA
Wang, Y., Li, W., Jia, L., Shen, J., Li, C., & Jia, H. (2025). The Early Effects of Esketamine on the Tumor Metastatic Microenvironment in Postoperative Lung Cancer Patients. The Clinical Respiratory Journal, 19(8). https://doi.org/10.1111/crj.70108
Vancouver
Wang Y, Li W, Jia L, Shen J, Li C, Jia H. The Early Effects of Esketamine on the Tumor Metastatic Microenvironment in Postoperative Lung Cancer Patients. The Clinical Respiratory Journal. 2025;19(8). doi:10.1111/crj.70108
BibTeX
@article{Wang2025,
author = {Wang, Yong and Li, Weijing and Jia, Li and Shen, Junmei and Li, Chao and Jia, Huiqun},
title = {The Early Effects of Esketamine on the Tumor Metastatic Microenvironment in Postoperative Lung Cancer Patients},
journal = {The Clinical Respiratory Journal},
year = {2025},
volume = {19},
number = {8},
doi = {10.1111/crj.70108}
}
EUVIMED